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Abstract It is widely known that Enterococcus faecalis
virulence is related to its biofilm formation. Although En-
terococci are common commensal organisms of the gastro-
intestinal tract, the difference between commensal and
pathogen strains remain unclear. In this study, we compare
the biochemical profile of the biofilms formed by two groups
of medical and two groups of commensal strains. The medical
strains were isolated as pathogens from infections of urinary
tract and other infections (wounds, pus and bedsores), and the
commensal strains were taken from faeces of healthy volun-
teers and faeces of wild mallards (Anas platyrhynchos) living
in an urban environment. The properties of biofilms formed
by medical and commensal strains differed significantly.
Commensal strains showed lower metabolic activity and glu-
cose uptake and higher biofilm biomass than the medical ones.
Consistent with glucose uptake experiments, we found that
the glucose dehydrogenase gene was more expressed in
medical strains. These results indicate that higher metabolic
activity and lower protein concentration of E. faecalis cells
within biofilms are formed during infections.
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Introduction
Enterococci are common commensal organisms of the gas-
trointestinal tract (Mohamed et al. 2004). On the other hand,
Enterococcus faecalis is one of the most common causes of
serious nosocomial and urinary tract infections (Sood et al.
2008). Despite many studies and recognition of virulence
factors (e.g. Eaton and Gasson 2001; Furumura et al. 2006;
Gülhan et al. 2006; Jarzembowski et al. 2009), processes
that determine host–Enterococcus relationships remain
poorly understood. Enterococci virulence could be related
to biofilm formation (Parsek and Singh 2003; Sood et al.
2008). In the biofilm, cells are organised into structured
communities enclosed within a matrix, and such a structure
is phenotypically different from that formed by planktonic
cells. Biofilm cells are more resistant to host defences and
display a significant decrease in susceptibility to antibiotics
(Costerton et al. 1999). The formation of cells occurs in
response to a variety of cues, including high cell density,
nutrient deprivation and physical environmental stress
(O’Toole et al. 2000). Bacterial biofilm causes significant
problems in many areas, both in the treatment and preven-
tion of infections (e.g. persistent and recurrent infections as
well as device-related infections) (Donlan and Costerton
2002). Enterococcus faecalis is capable of colonizing a wide
range of hosts and environments showing great genome
plasticity and diversity (Aakra et al. 2007). However,
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differences between an enterococcal pathogens and an ap-
parently safe commensal strains is unclear and little is
known about differences in biochemical properties between
commensal and pathogenic strains (Eaton and Gasson 2001;
Shiloach et al. 2010).
Our study aims to compare metabolic activity and
biofilm composition of pathogenic and commensal E.
faecalis strains with special emphasis on those isolated
from wild birds.
Materials and methods
Bacterial strains
A total of 65 strains of E. faecalis were examined,
including 32 commensal and 33 medical strains. Seven-
teen strains from the second group were isolated from
urinary tract infections (UTI) (urine and swabs of urinary
tract) and 16 strains from other infections (wounds, pus
and bedsores), and were all taken only from humans.
These samples were collected in the Kościerzyna Medi-
cal Centre. The commensal strains were isolated both
from humans (faecal samples from 16 volunteers) and
from wild birds living in urban environments (faecal
swabs taken from the cloaca of 16 mallards Anas platyr-
hynchos caught in Gdańsk). Isolates were identified and
recognized as a different E. faecalis strains by ID 32
STREP (bioMérieux).
For determination of biofilm dry weight, protein concen-
tration and biofilm metabolic activity as well as cell enu-
meration of all four groups of strains were taken into
account. For detection of glucose dehydrogenase gene ex-
pression, commensal strains from human and mallard faeces
and strains from urinary tract infections were chosen. Addi-
tionally, two strains from urinary tract infections, two from
human faeces and two from mallard faeces were randomly
chosen for analysis of growth curves.
Determination of biofilm dry weight
Biofilms formed in a sterile well plate after 72 h were
scraped from the bottom of the well, suspended in 1 ml
of 0.9 % NaCl and sonicated for 2 min on ice. Whole
volume of biofilm solution was carefully inoculated into
previously weighed cellulose membrane with pore size
0.2 μm (Whatman, Kent, UK). The membrane was placed
at 56 °C for 2 h and weighed again. Biofilm dry weights
were obtained as the differences between these two meas-
urements. As a negative control, a membrane inoculated
with sterile 0.9 % NaCl and dried as a sample was
weighed. The result was presented as a biomass of the
biofilm per 1 cm2 of its surface.
Cell enumeration
Biofilms formed in a sterile well plate after 72 h were
scraped from the bottom of the well, suspended in 1 ml of
0.9 % NaCl and sonicated for 2 min on ice. Then, 1 μl of the
sonicated biofilm sample was diluted in 103 and 106μl of
sterile 0.9 % NaCl. Next, 10 μl of diluted sample was plated
onto agar plates and incubated overnight (18–20 h) at 37 °C.
Inoculum of viable cells in the biofilm was determined by
the enumeration of colonies on the agar as colony-forming
units per 1 mg of biofilm (CFU/mg) and per 1 cm2 of
biofilm surface (CFU/cm2).
Determination of protein concentration
Protein concentration in the biofilm was determined using
the BCA Protein Assay Kit (Pierce, USA). Biofilms formed
in a sterile well plate after 72 h were scraped from the
bottom of the well, suspended in 1 ml of 0.9 % NaCl
and sonicated for 2 min on ice. Then, 20 μl of soni-
cated biofilm was sampled and the microplate procedure
was used according to the manufacturer’s instructions.
The result was presented per 1 cm2 of biofilm-forming
surface and 1 mg of the biofilm.
Determination of biofilm metabolic activity
Metabolic activity was measured by glucose uptake, reduc-
tion of the XTT and glucose dehydrogenase gene expres-
sion. Measuring glucose uptake was performed as described
earlier by Cerca et al. (2005) with a minor modification.
Briefly, cells in sterile 6-well plates (TRP, Switzerland) were
filled with 3 ml of Brain Heart Infusion (BHI) and inocu-
lated with 10 μl of an 18-h culture normalised to an optical
density of 0.5. As a control, additional wells were filled with
sterile BHI. After 24 h, 2 ml of medium was replaced with
fresh broth. The culture was terminated after 72 h, the
medium was aspirated and wells were washed with sterile
0.9 % NaCl. Next, 1 ml of 0.1 % solution of glucose was
added to each well and the plate was incubated for another
hour at 37 °C. After incubation, 10 μl was aspirated to
measure glucose concentration. Glucose uptake was deter-
mined with Glucose TR kit (Spinreact, Spain), measured at
505 nm with an ELISA reader and calculated as the differ-
ence between initial (0.1 %) and final glucose concentration.
XTT assay was performed using flat bottom polystyrene
plates (TRP). Bacterial strains were grown at 37 °C for 72 h
in BHI. After incubation, the medium was aspirated and the
wells were washed with 0.9 % NaCl. The metabolic activity
of the cells was determined with the Cell Proliferation Kit
(XTT-based) (Biological Industries) according to the manu-
facturer’s manual. This technique is focused on the meta-
bolic activity of viable cells and involves the use of
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tetrazolium salts, including 5-cyano-2,3-ditolyl tetrazolium
chloride (CTC) and 2,3-bis (2-methoxy-4-nitro-5-sulfo-
phenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydrox-
ide (XTT). The XTT assay is based on the reduction of the
XTT dye to water-soluble formazan (Roehm et al. 1991).
The absorbance of the cell supernatant is proportional to the
metabolic activity of the cells. In this study, the absorbance
was measured at 490 nm with an ELISA reader.
For FLOW-FISH detection of glucose dehydrogenase gene
expression, Molecular Beacon (MB) probes (CGCGAT
CCACCAGTCACGAATGATGCGATCGCG) were designed
with the software package (Beacon Designer; Biosoft). The
FLOW-FISH method allows the analysis of single/particular
cells in the sample and thus the evaluation of heterogeneity in
the bacterial population. FITC-labelled oligonucleotides were
synthesized commercially (Metabion) and tested for specificity
against the set of reference organisms. Molecular beacon
probes were additionally labelled with Dabcyl’5 as a quencher.
Enfl84 probe (Waar et al. 2005) targeting E. faecalis 16S RNA
and nonsense sequence probe was used respectively as a
positive and negative reference.
For hybridisation, the procedure described by Waar et al.
(2005) was adopted and modified according to the previous
pilot study (Jarzembowski et al. 2009). Briefly, the cell
membrane was permeabilizated by incubation for 30 min
at 37 °C in permeabilisation buffer (TE) consisting of 1 mg
lysozyme/ml (DNA Gdańsk). Then, the cells were sus-
pended in 1 ml of 0.9 % NaCl and sonicated for 2 min on
ice. Finally, the cells were centrifuged for 5 min at
2,500 rpm, washed and suspended in 200 μl PBS buffer.
Subsequently, 200 μl hybridisation buffer containing a
FITC-labelled probe (1 ng) was added. The probes were
hybridised for 45 min at Tm temperature.
Fluorescence of particles was determined by a FACS
Scan flow cytometer (Becton Dickinson, San Jose, CA,
USA). Percentage unstained particles (no. FL1<10/no.
FL1>10) and mean fluorescence per particle (FL1/FSC)
were analysed.
Growth curves determination
The isolates were grown on a Brain Heart Infusion Agar
(BHIA) plate at 37 °C for 48 h, after which they were
inoculated in Brain Heart Infusion (BHI) at 37 °C with
constant agitation (120 rpm). In order to evaluate the kinet-
ics growth, 200 μl of the suspension was removed every
hour and its optical density determined using a plate reader
with a wavelength of 640 nm.
Statistical analysis
Since a zero value was obtained in some cases, 0.001 was
added to all data in order to enable log-transformation of 0
values. All data were log-transformed (log10) to normal-
ise variables and a constant value of 3 was added
to bring minimum values after transformation to above
zero. Thus, the transformation followed the equation:
x’=log10(x+0.001)+3, where x is the original value and
x’ the value after transformation. Nested ANOVA were
used in all analyses with the four group of strains
(isolated as a pathogen from urine in urinary tract
infections, isolated as a pathogen from other infections,
isolated as a commensal from faeces of healthy volun-
teers and isolated as a commensal from faeces of birds
living in urban environments) nested in two strain types
(medical and commensal strains). Data obtained in per-
cent scale was transformed using arcsin√x function after
dividing the percentage by 100. Statistical methods fol-
lowed Zar (1996).
Results
Biochemical parameters of medical and commensal strains
differed to a large extent. In the case of glucose uptake, XTT
assay results and the number of colony-forming units
(CFU/mg) the differences between the means were the high-
est and exceeded 40 % (Table 1). Both medical and com-
mensal strains showed a wide range of CFU/mg and
CFU/cm2 values (Table 1), which means that densities of
cells in the biofilm differed greatly.
Meanmetabolic activity measured by XTT value per mg of
biofilm (XTT/mg), mean amount of protein per cm2, and
mean mass of biofilm per cm2 did not differ among the four
strains (nested ANOVA: among strains within strain type,
p>0.05 in all cases), but differed significantly between
medical and commensal types of strains (nested ANOVA,
F1,61=9.46, p=0.003 for amount of protein per cm
2,
F1,61=6.09, p=0.016 for mass of biofilm per cm
2 and
F1,61=10.21, p=0.002 for XTT result per mg of biofilm). Mean
XTT value per mg of biofilm in medical strains was
higher than in commensal ones, but for the mean amount
of protein per cm2 and mean mass of biofilm per cm2 of
surface, the results were opposite (Fig. 1).
Differences in glucose uptake between medical and com-
mensal strains occurred in relation to surface (nested
ANOVA among strains, F2,61=5.42, p=0.023) and to bio-
film biomass (nested ANOVA among strains, F2,61=10.25,
p=0.002). In both cases ,strains isolated from urinary infec-
tions had higher mean values than strains isolated from
human faeces (nested ANOVA and Neuman–Keuls post
hoc test, p<0.05) (Fig. 2).
Mean values of CFU/mg, CFU/cm2, amount of protein
per mg and XTT value per cell did not differ among the four
strain types (nested ANOVA: among strains within strain
type, p>0.05 in all cases).
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Between 20.2 and 98.7 % of particles considered as cells
were not bound by the probe targeting glucose dehydroge-
nase gene. The proportion was significantly lower in bird
strains than those from urinary infections and human faeces
(one-way ANOVA, F2,35=26.78, p<0.001 and Newman–
Table 1 Mean values and ranges of biochemical parameters for medical and commensal strains measured in this study
Biochemical parameter Medical strains Commensal strains Difference between means
Mean Range Mean Range
Biomass of biofilm (mg/cm2) 0.259 0.042–0.542 0.315 0.125–0.542 19.2 %
CFU/mg 22.656 0.238–88.889 11.504 0.077–38.095 49.2 %
CFU/cm2 4.922 0.069–16.667 3.648 0.042–12.222 25.8 %
Glucose uptake (μg/cm2) 0.461 0.038–1.655 0.270 0.000–1.358 41.3 %
Glucose uptake (μg/mg of biofilm) 1.072 0.046–8.521 0.344 0.000–2.148 68.2 %
Amount of protein (μg/cm2) 0.052 0.003–0.228 0.063 0.034–0.177 14.3 %
Amount of protein (μg/mg of biofilm) 0.202 0.009–0.608 0.217 0.090–0.663 10.0 %
XTT result (AU/mg of biofilm) 0.737 0.229–3.075 0.417 0.162–1.007 43.2 %
XTT result (AU/cell x105) 0.215 0.007–2.020 0.324 0.007–3.248 52.4 %
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Fig. 1 Differences in biochemical properties of biofilm formed by
commensal and medical strains. Vertical line 95 % confidence interval
around mean. All differences are statistically significant according to
Neuman–Keuls post hoc test at P <0.05 (dotted line)
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Fig. 2 Differences in glucose uptake between studied groups of strains
in relation to biofilm surface (a) and biofilm biomass (b). Filled square
strains isolated from patients with urinal infections, filled circle strains
isolated from other non-urinal infections, open triangle strains isolated
from birds, open diamond strains isolated from healthy people. Vertical
line 95 % confidence interval around mean. Dotted line joins strains
that differed significantly according to Neuman–Keuls post hoc test at
P < 0.05
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Keuls post hoc test, p<0.05) (Fig. 3). Also, mean fluores-
cence (FL1) of bound cells was lower in strains isolated
from mallards comparing with both samples from humans
(one-way ANOVA, F2,35=3.63, p=0.037) with statistically
significant differences between strains from bird and human
faeces (Newman–Keuls post hoc test, p=0.038) (Fig. 3).
Differences were also observed in population growth
rate. Medical strains have a similar behaviour, with a sharper
exponential phase and reaching a higher plateau character-
istic of the stationary phase. The exponential phase for all
bacteria tested lasts 3 h from the moment of the inoculum
(Fig. 4). Bird isolates were the strains with the most different
behaviour, as their growth rate in exponential phase is much
smaller than any other strain. Both faecal strains have a similar
behaviour having an intermediate growth rate in comparison
to medical isolates, which have the highest growth rate and
bird isolates which have the lowest growth rate (Fig. 4).
Discussion
We showed that medical strains of E. faecalis display higher
metabolic activity and lower biomass in biofims than com-
mensal strains. Our results suggest that metabolic activity of
enterococci does not correlate with higher cell concentra-
tions in biofilms. It is possible that increases in EPS pro-
duction might account for lower biomass in some biofilm-
forming strains. However, we have not investigated this
point, as we have focused our attention on the cellular
component of enterococcal biofilms.
We revealed that the medical strains of E. faecalis had
higher metabolic activity and lower biomass of biofilm than
the commensal strains. These results indicate that higher
metabolic activity of enterococci was not related to higher
concentration of cells in biofilm. Low biomass of biofilm
can be the result of spread adaptation of the medical strain
(Ahimou et al. 2007).
Glucose uptake was significantly higher in strains isolat-
ed from patients with urinal infections in comparison with
those from healthy people. The same differences were ob-
served at the transcription level (FLOW-FISH results) and
when we compare growth curves. It is obvious that frequent
cell division demands higher metabolic activity. On the
other hand, the correlation of the results obtained by three
different approaches means the difference between the stud-
ied strains is evident.
Some studies have shown that among E. faecalis, glucose
supplementation enhances biofilm formation (Baldassarri et
al. 2001), whereas other researchers have demonstrated
glucose-mediated inhibition of biofilm production (Kristich
et al. 2004). This divergence might be a result of a bimodal
fashion of glucose-mediated biofilm formation, where great-
er biomass of biofilm would be created at the extremes of
the environmental conditions, which could potentially pro-
vide the organism with a survival benefit in suboptimal
growth conditions (Pillai et al. 2004). However, glucose
uptake might result from cell density and correlate with
the density of CFU in the biofilms (Cerca et al. 2005).
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Fig. 4 Growth curves of two commensal strains from mallards (thick
lines), two strains from humans’ urinary infection (thin lines) and two
commensal strains from human faeces (dashed lines) presented in
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Although we showed statistically significant differences
in biochemical properties between the medical and the com-
mensal strains, it should be noted that environmental and
clinical biofilms rarely, if ever, consist only of cells from a
single species. Therefore, further studies are needed to ana-
lyse the influence of other species on E. faecalis biofilm.
Moreover, when comparing results obtained from bird and
human strains, differences in ammonia metabolism should
be considered. Birds excrete urate instead of the toxic urea
as do mammals. Urea in mammals is flushed out from the
body with a great amount of water, while urate in birds is
largely insoluble and uses very little water to be excreted
(Goldstein and Skadhauge 1999). Thus, differences between
strains collected from birds and from humans might be
caused by biochemical adaptations to different media.
Not only glucose uptake but also lower amounts of protein
found in the medical strains suggests slower growth of biofilm
in these strain types in comparison with the commensal ones.
This comes from the assumption that the concentration of
proteins increases during biofilm development (Toledo-Arana
et al. 2001; Tendolkar et al. 2004) and surface proteins can
mediate biofilm formation (Geoghegan et al. 2010).
We have found marked differences in the biochemical
properties of biofilms formed by strains of different origins.
The medical strains formed thinner biofilm (lower amount
of cells on the same area) with higher metabolic activity
than the commensal strains. However, because of high di-
vergence of features within groups of strains, it is still
impossible to “forecast” bacteria–host relationships based
on the biochemical properties of their biofilms.
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